Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Therapy-Related Toxicity”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Not Yet RecruitingNCT07110662
What this trial is testing

New Therapeutic Target for Toxic Epidermal Necrolysis (TEN) Using Anti-CD38+ Monoclonal Antibodies.

Who this might be right for
Toxic Epidermal NecrolysisImmunotherapyCutaneous Adverse Drug Reactions (CADR)
Hospices Civils de Lyon 9
Not applicableActive Not RecruitingNCT04305613
What this trial is testing

Cardiotoxicity in Locally Advanced Lung Cancer Patients Treated With Chemoradiation Therapy

Who this might be right for
CardiotoxicityLung Cancer Stage IIILung Cancer Stage II+1 more
Abramson Cancer Center at Penn Medicine 221
Post-approval studies (Phase 4)Active Not RecruitingNCT04928261
What this trial is testing

Evaluating 6-months of HER2-targeted Therapy in Patients With HER2 Positive Early-stage Breast Cancer That Achieve a Pathological Complete Response to Neoadjuvant Systemic Therapy

Who this might be right for
Breast Cancer
Ottawa Hospital Research Institute 52
Not applicableLooking for participantsNCT04659343
What this trial is testing

TDM for Optimized Outcome in Patients With mRCC.

Who this might be right for
Kidney CancerRenal Cell Carcinoma MetastaticDrug Toxicity+2 more
Niels Fristrup 200
Large-scale testing (Phase 3)Study completedNCT00358501
What this trial is testing

Defibrotide for the Treatment of Severe Hepatic Veno-Occlusive Disease in Hematopoetic Stem Cell Transplant Patients

Who this might be right for
Severe Hepatic Veno-Occlusive Disease
Jazz Pharmaceuticals 134
Testing effectiveness (Phase 2)Study completedNCT00740415
What this trial is testing

Rituximab, Bortezomib,Bendamustine , Dexamethasone, Patients With Mantle Cell Lymphoma

Who this might be right for
Lymphoma
French Innovative Leukemia Organisation 39
Not applicableNot Yet RecruitingNCT06924645
What this trial is testing

Fecal Microbiota Transplantation for Preventing Gastrointestinal Symptoms in Extrapulmonary Neuroendocrine Neoplasms: A Real-World Study

Who this might be right for
Treatment-related Gastrointestinal Toxicity (Including Diarrhea, Constipation, Nausea, and Vomiting)Extrapulmonary Neuroendocrine Neoplasms
Second Affiliated Hospital, Zhejiang University, School of Medicine 40
Post-approval studies (Phase 4)UnknownNCT01141322
What this trial is testing

Cholestatic Drug-induced Liver Injury

Who this might be right for
Hepatitis, Toxic
Taipei Veterans General Hospital, Taiwan 180
Testing effectiveness (Phase 2)UnknownNCT06118047
What this trial is testing

Crisaborole Ointment for Skin Toxicity Induced by Cetuximab

Who this might be right for
Metastatic Colorectal CancerCetuximabSkin Toxicity
Sun Yat-sen University 33
Not applicableUnknownNCT05892146
What this trial is testing

Strategy Therapy on Cancer Therapy-Related Cardiac Dysfunction

Who this might be right for
Chemotherapeutic ToxicityCardiotoxicityHeart Failure+2 more
National Cheng-Kung University Hospital 100
Not applicableEnded earlyNCT00813501
What this trial is testing

Immunologic Diagnostic Blood Test in Predicting Side-Effects in Patients Undergoing a Donor Stem Cell Transplant for Hematologic Cancer or Other Diseases

Who this might be right for
Chronic Myeloproliferative DisordersGraft Versus Host DiseaseInfection+7 more
City of Hope Medical Center 60
Large-scale testing (Phase 3)Study completedNCT00221702
What this trial is testing

PegIntron Versus IntronA in CMAJCC Stage II (EADO 2001/CMII Trial)

Who this might be right for
MelanomaNeoplasm Metastasis
University Hospital, Bordeaux 898
Testing effectiveness (Phase 2)UnknownNCT00003583
What this trial is testing

Amifostine to Prevent Side Effects in Patients Who Are Receiving Chemotherapy and Radiation Therapy for Limited-Stage Small Cell Lung Cancer

Who this might be right for
Drug/Agent Toxicity by Tissue/OrganLung CancerRadiation Toxicity
University of Florida 20
Large-scale testing (Phase 3)Study completedNCT01230983
What this trial is testing

Combination Chemotherapy in Treating Patients With Acute Lymphoblastic Leukemia or Advanced Lymphoblastic Non-Hodgkin's Lymphoma

Who this might be right for
Cardiac ToxicityLeukemiaLymphoma
Children's Oncology Group 573
Large-scale testing (Phase 3)UnknownNCT05728632
What this trial is testing

Cardioprotective Effects of Nebivolol Versus Placebo in Patients Undergoing Chemotherapy With Anthracyclines

Who this might be right for
Breast CancerLymphoma, Large B-Cell, DiffuseCardiotoxicity+2 more
Giulio Stefanini 80
Large-scale testing (Phase 3)Study completedNCT00017004
What this trial is testing

Radiation Therapy and Cisplatin With or Without Epoetin Alfa in Treating Patients With Cervical Cancer and Anemia

Who this might be right for
AnemiaCervical AdenocarcinomaCervical Adenosquamous Carcinoma+6 more
Gynecologic Oncology Group 114
Not applicableStudy completedNCT05691309
What this trial is testing

Optimizing Vancomycin Therapy in Children

Who this might be right for
SepsisCritical IllnessInfections+1 more
Children's Hospital of Philadelphia 29
Not applicableUnknownNCT05927636
What this trial is testing

Systemic Treatment Related Toxicity Identified With a Smartphone APPlication Measuring Step Count

Who this might be right for
CancerSystemic TreatmentPhysical Activity+1 more
Radboud University Medical Center 411
Testing effectiveness (Phase 2)Study completedNCT02445742
What this trial is testing

CML Treated With Bosutinib After Relapse

Who this might be right for
Chronic Myeloblastic Leukaemia
PETHEMA Foundation 30
Testing effectiveness (Phase 2)Active Not RecruitingNCT06399029
What this trial is testing

Topical Ruxolitinib Evaluation in Immune-related Lichenoid Skin-Toxicities

Who this might be right for
ExanthemaLichenoid Skin Rashes Under Anti-PD1 Tumor Therapy
University of Zurich 22
Next Page